Metabolic Syndrome Among People Living with HIV Receiving Medical Care in Southern United States: Prevalence and Risk Factors

• Published in: AIDS and behavior Vol. 23; no. 11; pp. 2916 - 2925
• Main Authors: Sears, Sabeena, Buendia, Justin R., Odem, Sylvia, Qobadi, Mina, Wortley, Pascale, Mgbere, Osaro, Sanders, Jontae, Spencer, Emma C., Barnes, Arti
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.11.2019; Springer Nature B.V
• Subjects: Adult; Aging; Anti-Retroviral Agents - adverse effects; Anti-Retroviral Agents - therapeutic use; Antiretroviral agents; Antiretroviral drugs; Antiretroviral Therapy, Highly Active - adverse effects; Antiretroviral Therapy, Highly Active - methods; Body Mass Index; Body weight; Cardiovascular Diseases - epidemiology; Chronic illnesses; Cross-Sectional Studies; Demographics; Diabetes Mellitus, Type 2 - epidemiology; Female; Health Psychology; Health risks; Health services; HIV; HIV Infections - complications; HIV Infections - drug therapy; HIV Infections - epidemiology; Human immunodeficiency virus; Humans; Hypertension - epidemiology; Infectious Diseases; Male; Medicine; Medicine & Public Health; Men; Metabolic disorders; Metabolic syndrome; Metabolic Syndrome - epidemiology; Middle Aged; Obesity; Obesity - epidemiology; Original Paper; Overweight; Prescription drugs; Prevalence; Public Health; Risk analysis; Risk Factors; Sexually transmitted diseases; STD; Tests; United States - epidemiology; Viral Load; United States; Mississippi; Georgia; Florida; United States > US; Texas; Medical Monitoring Project; Southern United States; HIV; Metabolic syndrome
• ISSN: 1090-7165; 1573-3254
• DOI: 10.1007/s10461-019-02487-8

Using representative data among 1861 in care people living with HIV (PLWH) in four southern states (Texas, Mississippi, Florida, and Georgia) from the 2013–2014 Medical Monitoring Project (MMP) survey, we estimated the prevalence and odds of metabolic syndrome (MetS) among various demographic and HIV related risk factors. Overall MetS prevalence was 34%, with our participants being mostly black (55%), male (72%), ≥ 50 years old (46%), and overweight or obese (60%) with undetectable viral loads (≤ 200 copies/ml, 69%), and were currently taking antiretroviral medication (98%). Compared to those who were ≥ 60 years, 18–39 year olds had a 79% (95% CI 0.13–0.33) lower odds of having MetS. Women were 2.24 times more likely to have MetS than men (95% CI 1.69–2.97). Age and sex were significant predictors of MetS. Since MetS is a combination of chronic disease risk factors, regular screening for MetS risk factors among aging PLWH is crucial.